InvestorsHub Logo
Followers 74
Posts 2371
Boards Moderated 0
Alias Born 09/07/2014

Re: hankmanhub post# 698959

Monday, 06/17/2024 1:09:04 PM

Monday, June 17, 2024 1:09:04 PM

Post# of 704240

NWBO) (“NW Bio”), a biotechnology company developing DCVax® personalized immune therapies for solid tumor cancers, announced today that on June 12, 2024 it entered into an exclusive license from Roswell Park Comprehensive Cancer Center for a portfolio of dendritic cell technologies and intellectual property (IP).



That's the first sentence of the PR, Hankmanhub. Please read it again and note the word "exclusive". You mis-represented my post when you quoted that the former in-licensing from last yearwas "exclusive" but the one we just secured from Roswell was not.

So now we know that both portfolios in-licensed by NWBO from Dr. Kalinski's work are exclusively licensed to NWBO, and NWBO alone.
Bullish
Bullish
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News